NEUCHATEL, Switzerland-- (BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97 ™ Pulse CO-Oximeter ®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ ...
Rad-97 offers Masimo noninvasive and continuous monitoring, through Measure-through Motion and Low Perfusion™ SET ® pulse oximetry and upgradeable rainbow ® technologies, in a compact, standalone ...
Irvine, CA-based Masimo Corporation MASI recently announced the 510(k) clearance and full-market release of its proprietary Rad-97 Pulse CO-Oximeter. The launch of Rad-97 offers Masimo noninvasive and ...
Masimo Corporation (NASDAQ: MASI) received FDA approval for the domestic use of Rad-97 Pulse CO-Oximeter. This product will offer non-invasive and continuous monitoring. The product comprises ...
Masimo (NASDAQ: MASI) announced today the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter ® and connectivity hub. Rad-97 offers Measure-through Motion ...
Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97 ™ Pulse CO-Oximeter ®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ SET ® pulse oximetry and upgradeable rainbow ...
Masimo Corporation MASI received FDA approval for the domestic use of Rad-97 Pulse CO-Oximeter. This product will offer non-invasive and continuous monitoring. The product comprises Measure-through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback